Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
IBM
IBM
|
$320M |
| 2 |
Johnson & Johnson
JNJ
|
$221M |
| 3 |
GE Aerospace
GE
|
$156M |
| 4 |
Walt Disney
DIS
|
$154M |
| 5 |
Target
TGT
|
$145M |
Top Sells
| 1 |
Apple
AAPL
|
$283M |
| 2 |
Eli Lilly
LLY
|
$203M |
| 3 |
Microsoft
MSFT
|
$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
$194M |
| 5 |
Citigroup
C
|
$177M |
Sector Composition
| 1 | Technology | 14.01% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.91% |
| 5 | Industrials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SDRL
226
DELISTED
Seadrill Limited Common Stock
SDRL
| $41.3M | 0.1% |
3,421
-3,903
| -53% | -$47.1M |
|
227
Micron Technology
MU
$148B
| $41.3M | 0.1% |
+2,361,836
| New | +$41.3M |
|
|
FLIR
228
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $41M | 0.1% |
1,305,960
-548,400
| -30% | -$17.2M |
|
229
Healthpeak Properties
DOC
$12.6B
| $40.8M | 0.1% |
1,095,145
-549,000
| -33% | -$20.5M |
|
230
TE Connectivity
TEL
$61.3B
| $40.8M | 0.1% |
+788,000
| New | +$40.8M |
|
231
Grifois
GRFS
$6.9B
| $40.7M | 0.1% |
2,685,308
-56,000
| -2% | -$848K |
|
232
Ross Stores
ROST
$49.7B
| $40.6M | 0.1% |
1,114,400
+448,472
| +67% | +$16.3M |
|
233
iShares MSCI Emerging Markets ETF
EEM
$19.3B
| $40.5M | 0.1% |
+994,600
| New | +$40.5M |
|
234
Oneok
OKE
$44.9B
| $40.5M | 0.1% |
868,300
-632,094
| -42% | -$29.5M |
|
|
MON
235
DELISTED
Monsanto Co
MON
| $40.2M | 0.1% |
385,600
-136,100
| -26% | -$14.2M |
|
236
CSG Systems International
CSGS
$1.87B
| $40.1M | 0.1% |
1,600,722
+59,200
| +4% | +$1.48M |
|
237
Enterprise Products Partners
EPD
$68.1B
| $40.1M | 0.1% |
1,313,646
+197,000
| +18% | +$6.01M |
|
238
Franklin Resources
BEN
$12.9B
| $39.8M | 0.1% |
787,000
-836,600
| -52% | -$42.3M |
|
|
PCYC
239
DELISTED
PHARMACYCLICS INC
PCYC
| $39.5M | 0.1% |
+285,500
| New | +$39.5M |
|
|
ANN
240
DELISTED
ANN INC
ANN
| $39.3M | 0.1% |
1,084,200
-485,300
| -31% | -$17.6M |
|
241
Genuine Parts
GPC
$19.4B
| $39.2M | 0.1% |
+484,800
| New | +$39.2M |
|
242
CorVel
CRVL
$4.63B
| $38.7M | 0.09% |
3,138,600
+65,400
| +2% | +$806K |
|
243
Unilever
UL
$157B
| $38.6M | 0.09% |
999,840
+736,000
| +279% | +$28.4M |
|
244
Visteon
VC
$3.51B
| $38.1M | 0.09% |
503,500
-160,700
| -24% | -$12.2M |
|
245
Credit Acceptance
CACC
$5.79B
| $38M | 0.09% |
342,800
| – | – |
|
246
Compañía de Minas Buenaventura
BVN
$5.07B
| $37.9M | 0.09% |
3,233,300
+1,612,100
| +99% | +$18.9M |
|
247
Berkshire Hathaway Class B
BRK.B
$1.07T
| $37.8M | 0.09% |
+333,000
| New | +$37.8M |
|
248
Tyson Foods
TSN
$19.8B
| $37.8M | 0.09% |
+1,336,100
| New | +$37.8M |
|
249
Parker-Hannifin
PH
$96.1B
| $37.7M | 0.09% |
+346,350
| New | +$37.7M |
|
250
Core Laboratories
CLB
$594M
| $37.6M | 0.09% |
222,500
+5,000
| +2% | +$846K |
|